Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) Autor Arteaga-Muller,Giovanna (1) Bai,Nan (1) Camacho-Ortiz,Adrián (1) Di,Xiuzhen (1) Galván-de los Santos,Alejandra María (1) Garza-González,Elvira (1) Hernández-García,Raúl (1) Liang,Beibei (1) Liu,Bin (1) Liu,Youning (1) Miller,Mark (1) Ni,Wentao (1) Wang,Jin (1) Wang,Kai (1) Wang,Rui (1) Zhang,Xin (1) Mais... Palavra-chave Clostridium difficile (2) Clostridium difficileinfection (CDI) (1) Metronidazole (1) Mortality (1) Prediction rule (1) Vancomycin (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2015 (2) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity BJID Di,Xiuzhen; Bai,Nan; Zhang,Xin; Liu,Bin; Ni,Wentao; Wang,Jin; Wang,Kai; Liang,Beibei; Liu,Youning; Wang,Rui. The aim of this meta-analysis was to compare the efficacy of metronidazole and vancomycin for the treatment of Clostridium difficileinfection, especially to investigate which agent was superior for treating either mild or severe C. difficileinfection. A meta-analysis of randomized controlled trials and cohort studies identified in Pubmed, Embase, and the Cochrane Library was conducted. Four randomized controlled trials and two cohort studies involving 1218 patients were included in this meta-analysis. Metronidazole was inferior to vancomycin for treating C. difficileinfection in terms of both initial clinical cure rates (risk ratio, RR = 0.91, 95% confidence interval, CI = 0.84-0.98, p= 0.02) and sustained cure rates (RR = 0.88, 95% CI = 0.82-0.96, p= 0.003).... Tipo: Info:eu-repo/semantics/article Palavras-chave: Clostridium difficile; Clostridium difficileinfection (CDI); Vancomycin; Metronidazole. Ano: 2015 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702015000400339 Application of the ATLAS score for evaluating the severity of Clostridium difficile infection in teaching hospitals in Mexico BJID Hernández-García,Raúl; Garza-González,Elvira; Miller,Mark; Arteaga-Muller,Giovanna; Galván-de los Santos,Alejandra María; Camacho-Ortiz,Adrián. Background: For clinicians, a practical bedside tool for severity assessment and prognosis of patients with Clostridium difficileinfection is a highly desirable unmet medical need.Setting: Two general teaching hospitals in northeast Mexico.Population: Adult patients with C. difficileinfection.Methods: Prospective observational study.Results: Patients included had a median of 48 years of age, 54% of male gender and an average of 24.3 days length of hospital stay. Third generation cephalosporins were the antibiotics most commonly used prior to C. difficileinfection diagnosis. Patients diagnosed with C. difficileinfection had a median ATLAS score of 4 and 56.7% of the subjects had a score between 4 and 7 points. Patients with a score of 8 through 10 points had... Tipo: Info:eu-repo/semantics/article Palavras-chave: Clostridium difficile; Prediction rule; Mortality. Ano: 2015 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702015000400399 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco